Z-2937-2026 Class II Ongoing
FDA device recall Z-2937-2026 was initiated by Bioporto Diagnostics A/S on May 18, 2026 and is designated Class II. Reason for recall: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in… The recall status is ongoing. Affected quantity: 400 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 19, 2026
- Initiation Date
- May 18, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 400 units
Product description
ProNephro AKI (NGAL) Reagent Kit (100 tests). IVD Acute Kidney Injury Test System.
Reason for recall
The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.
Distribution pattern
Worldwide - The affected product distribution included the United States and the countries of European Union, Chile, and Hong Kong. No affected product was distributed to Canada; however, Health Canada was notified because the product is registered in Canada.
Code information
Model number: ST101UB / 08787174 190; GTIN code: 5711435000156; Lot-number: 04909125 and 04912125.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2937-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026